Ardsley Advisory Partners’s St Jude Medical STJ Stock Holding History

Ardsley Advisory Partners’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-5,000	Closed	-$327K	–	325
2014 Q1	$327K	Hold	5,000	–	–	0.05%	176
2013 Q4	$310K	Sell	5,000 -2,500	-33%	-$145K	0.04%	120
2013 Q3	$402K	Buy	+7,500	New	+$386K	0.08%	86

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IIS

Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ardsley Advisory Partners's STJ Position: Q2 2014 in Review

Ardsley Advisory Partners sold out of St Jude Medical (STJ) in Q2 2014, closing a stake of 5,000 shares — an estimated $327K sold.

Ardsley Advisory Partners first reported a position in STJ in Q3 2013 and held it in 3 quarters. The position peaked at $402K in Q3 2013. 555 funds tracked by Wall St. Rank hold STJ as of Q2 2014.

Ardsley Advisory Partners reported no remaining St Jude Medical position as of Q2 2014 after selling out during the quarter.
Ardsley Advisory Partners sold 5,000 St Jude Medical shares in Q2 2014, an estimated $327K.
Ardsley Advisory Partners first reported a position in St Jude Medical in Q3 2013 and held it in 3 quarters.
Ardsley Advisory Partners's St Jude Medical position peaked at $402K in Q3 2013.
555 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2014.

Based on Ardsley Advisory Partners's 13F filing for Q2 2014, filed 14 Aug 2014.